Medical Research
(H80)
990 on File
CENTRAL NEW YORK LYME AND TICK-BORNE DISEASE ALLIANCE INC
Financial strength (30%)
67/100
Reliability (20%)
45/100
Effectiveness (25%)
78/100
Impact (25%)
No data yet
CharityAI™ Score
Not yet evaluated
Financial Overview — FY 2025
$402K
Total Revenue
$411K
Total Expenses
$317K
Net Assets
4
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
83.6%
Fundraising Efficiency
116.7%
Operating Reserve
9.27x
Liability-to-Asset
2.0%
Revenue Diversification
93.4%
Executive Compensation
$114K
Compared with Peers
FY 2025
Compared with 300 similar organizations
(United States, Medical Research, $100K–$1M in expenses), FY 2025.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
83.6% | 84.6% |
P10P90
|
Below median |
|
Admin expense ratio
Management and general / total expenses
· lower is better
|
10.3% | 10.0% |
P10P90
|
Below median |
|
Fundraising expense ratio
Fundraising expenses / total expenses
· lower is better
|
6.0% | 0.0% |
P10P90
|
Bottom quarter |
|
Fundraising efficiency
Fundraising expenses / gross fundraising income
· lower is better
|
116.7% | 10.1% |
P10P90
|
Bottom quarter |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
9.3 mo | 11.7 mo |
P10P90
|
Below median |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
2.0% | 0.0% |
P10P90
|
Below median |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
93.4% | 92.2% |
P10P90
|
Below median |
|
Revenue growth
Year over year revenue growth
|
-17.4% | 3.4% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
-0.3% | 7.5% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
-2.2% | -1.6% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2025 | $402K | $411K | $317K | 83.6% | 4 |
| 2024 | $487K | $412K | $326K | 74.8% | 5 |
| 2023 | $343K | $379K | $252K | 76.1% | 4 |
| 2022 | $304K | $291K | $287K | 84.0% | 2 |
| 2021 | $560K | $259K | N/A | — | 2 |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.